Corneal collagen cross-linking is now FDA approved and is a mainstay of the U.S. and global armamentarium for patients with potentially progressive keratoconus.
A recent meta-analysis of the prevalence and risk factors for keratoconus suggested that patients with a history of eye rubbing, family history of keratoconus, allergies, asthma and eczema were at a higher risk for keratoconus than the general population. The researchers suggested a prevalence of 1.38 per 1,000 population. In studies that reported gender, the prevalence in men was 20.6 per 1,000 and 18.33 per 1,000 in (Read more...)
Uncategorized